
UNC a lead site in clinical trial of three hepatitis C medications
Dr. Michael Fried, director of the UNC Liver Center, is a co-principal investigator of the PRIORITIZE Study.
Dr. Michael Fried, director of the UNC Liver Center, is a co-principal investigator of the PRIORITIZE Study.
UNC School of Medicine faculty members took on critical roles in amending diagnostic criteria questionnaires for functional GI disorders, which affect millions of people worldwide.
A research question posed through the Crohn’s & Colitis Foundation of America (CCFA) Partners Patient-Powered Research Network CCFA Partners – a collaboration between UNC and the CCFA – served as motivation for this study concept.
Scientists from the UNC / NC State joint biomedical engineering department are creating a new kind of research tool that will be nearly indistinguishable from the human gastrointestinal tract.
Protecting the gastrointestinal system during chemotherapy or radiation could allow patients to tolerate more aggressive treatments to attack tumors.
Their article, published in The New England Journal of Medicine, explores the pros and cons of five different interventional approaches to treating gallbladder disease – a condition that affects more than 25 million Americans.
This award was established in 1941 to recognize an individual who has contributed significantly to the American Gastronterological Association and has made lifelong contributions to the field of gastroenterology. This is the highest honor bestowed upon an AGA member.
Established by the American Gastroenterological Association (AGA) in 2004, the Distinguished Mentor Award recognizes two individuals each year for achievements as outstanding mentors over a lifelong career.
A new study by UNC researchers has found dramatic improvements in the care of patients with cirrhosis and liver failure and recommends improved treatment strategies for patients with cirrhosis and concurrent bacterial infections.
UNC stem cell expert Scott Magness, PhD, and Duke microbiome researcher John Rawls, PhD, are using a $50,000 grant to develop a new technology to study the co-dependent relationship between the human gut and its resident bacteria.